Conformis, Inc. (NASDAQ:CFMS) has a beta value of 1.81 and has seen 650,597 shares traded in the last trading session. The company, currently valued at $60.42 Million, closed the last trade at $0.78 per share which meant it gained $0.02 on the day or 2.39% during that session. The CFMS stock price is -210.26% off its 52-week high price of $2.42 and 35.9% above the 52-week low of $0.5. If we look at the company’s 10-day average daily trading volume, we find that it stood at 313.24 Million shares traded. The 3-month trading volume is 488.98 Million shares.
The consensus among analysts is that Conformis, Inc. (CFMS) is an Overweight stock at the moment, with a recommendation rating of 2. 1 analysts rate the stock as a Sell, while none rate it as Overweight. None out of 4 have rated it as a Hold, with 3 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.12.
Conformis, Inc. (NASDAQ:CFMS) trade information
Sporting 2.39% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Friday, Oct 16 when the CFMS stock price touched $0.8 or saw a rise of 2.61%. Year-to-date, Conformis, Inc. shares have moved -48.06%, while the 5-day performance has seen it change 1.95%. Over the past 30 days, the shares of Conformis, Inc. (NASDAQ:CFMS) have changed -10.24%. Short interest in the company has seen 577.5 Million shares shorted with days to cover at 1.18.
Wall Street analysts have a consensus price target for the stock at $2.33, which means that the shares’ value could jump 198.72% from current levels. The projected low price target is $2 while the price target rests at a high of $3. In that case, then, we find that the current price level is +284.62% off the targeted high while a plunge would see the stock lose 156.41% from current levels.
Conformis, Inc. (CFMS) estimates and forecasts
Figures show that Conformis, Inc. shares have underperformed across the wider relevant industry. The company’s shares have gained +14.78% over the past 6 months, with this year growth rate of 0%, compared to 5.7% for the industry. Other than that, the company has, however, increased its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are 7.7% and -12.5% for the next quarter. Revenue growth from the last financial year stood is estimated to be -8.6%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +17.6% over the past 5 years. Earnings growth for 2020 is a modest +39.7% while over the next 5 years, the company’s earnings are expected to increase by -14.58%.
Conformis, Inc. (NASDAQ:CFMS)’s Major holders
Insiders own 9.56% of the company shares, while shares held by institutions stand at 40.24% with a share float percentage of 44.49%. Investors are also buoyed by the number of investors in a company, with Conformis, Inc. having a total of 106 institutions that hold shares in the company. The top two institutional holders are Renaissance Technologies, LLC with over 5.03 Million shares worth more than $4.12 Million. As of June 29, 2020, Renaissance Technologies, LLC held 6.48% of shares outstanding.
The other major institutional holder is Archon Capital Management LLC, with the holding of over 4.32 Million shares as of June 29, 2020. The firm’s total holdings are worth over $3.55 Million and represent 5.58% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of June 29, 2020, the former fund manager holds about 2.45% shares in the company for having 1903523 shares of worth $1.56 Million while later fund manager owns 991.09 Thousand shares of worth $812.7 Thousand as of June 29, 2020, which makes it owner of about 1.28% of company’s outstanding stock.